NR3C1 and B-cell chronic lymphocytic leukemia: PDE4 inhibitors Roflumilast could up-regulate glucocorticoid receptor (GRa) transcript levels in B Cell Chronic Lymphocytic Leukemia (B-CLL) cells but not T-CLL cells to enhance the glucocorticoid-mediated apoptosis [21].